Greg Moeck
About Greg Moeck
Greg Moeck: Senior Vice President, Microbiology
Greg Moeck holds the position of Senior Vice President, Microbiology. He possesses deep expertise in the field, evidenced by his extensive research and professional background. Moeck's role involves overseeing microbiological research and development, applying his specialized knowledge in the field to drive scientific innovation.
Greg Moeck's Education and Expertise in Microbiology
Greg Moeck earned his Ph.D. in Microbiology and Immunology from McGill University in Montreal, Quebec. His academic background is complemented by post-doctoral research at the University of Paris XI, with a focus on iron acquisition in gram-negative bacterial pathogens. These academic credentials are bolstered by his fellowship with both the Natural Sciences and Engineering Research Council of Canada and the Ministry of Foreign Affairs, France.
Greg Moeck's Professional Background
Greg Moeck's professional journey includes notable roles such as Vice President, Biology at The Medicines Company, and Senior Director of Biology at Targanta Therapeutics. These positions have helped him accumulate substantial experience in biological research and development, primarily focused on microbiology and immunology.
Greg Moeck's Publications and Patents
Throughout his career, Greg Moeck has published over 50 papers in peer-reviewed journals and co-authored three book chapters. His contributions to scientific literature demonstrate his expertise and significant input in the field of microbiology. Additionally, he is a co-inventor on four patents related to methods for treating bacterial infections, showcasing his innovation and practical contributions to medical science.